NewAmsterdam Pharma NAMS
NASDAQ NAMS
$21.58 +0.09 (+0.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Short-term Investments (2024 - 2026)

Updated

NewAmsterdam Pharma's Short-term Investments came in at $209.7 million for Q2 2026, up 19.6% from $175.3 million a year earlier and up 17.5% from the prior quarter.

Analysis

NewAmsterdam Pharma (NAMS) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, NewAmsterdam Pharma's Short-term Investments was $146.24 million, up 134.2% from FY2024.

  • Going back by year, Short-term Investments was $62.45 million in FY2024.
  • Year-over-year, Short-term Investments has increased for three consecutive quarters.
  • Business Quant data shows NAMS's Short-term Investments at $178.5 million (Q1 2026), $146.24 million (Q4 2025) and $164.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 NewAmsterdam Pharma 2.53 Bn -78.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 209.70 Mn
Mar 31, 2026 178.50 Mn
Dec 31, 2025 146.24 Mn
Sep 30, 2025 164.54 Mn
Jun 30, 2025 175.30 Mn
Mar 31, 2025 60.06 Mn
Dec 31, 2024 62.45 Mn
API Access

NewAmsterdam Pharma Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=NAMS&period=max&api_key=YOUR_API_KEY